Nav: Home

Complications from thyroid cancer surgery more common than believed, study finds

May 16, 2017

ANN ARBOR, Michigan -- As thyroid cancer rates rise, more people are having surgery to remove all or part of their thyroid. A new study suggests complications from these procedures are more common than previously believed.

Overall, 6.5 percent of thyroid cancer patients had general post-operative complications in the month after surgery, and 12 percent had complications specific to thyroid surgery within the year after their operation. But the risks were significantly higher for certain groups, suggesting the opportunity for targeted interventions and education to improve outcomes.

"That 12 percent of patients overall had thyroid surgery specific complications is concerning. Most of our surgeons quote a 1 to 3 percent rate. This is quadruple what we had thought," says lead study author Maria Papaleontiou, M.D., assistant professor of metabolism, endocrinology and diabetes at Michigan Medicine.

The majority of previous studies on thyroid surgery complications have been from single institutions, often high-volume centers, which are known to have better outcomes.

The new study, published in the Journal of Clinical Endocrinology and Metabolism, looked at 22,867 people who had surgery for thyroid cancer between 1998-2011. Data was collected from the Surveillance, Epidemiology and End Results-Medicare linked database.

Researchers looked at general post-operative complications - fever, infection, blood clots or swelling - that occurred within the first 30 days after surgery. They also looked at complications specific to thyroid surgery, such as hypoparathyroidism, hypocalcemia, and vocal cord or fold paralysis. These conditions can have lifelong impact on patients.

"When we work with patients to treat thyroid cancer, we're always balancing benefits and risks. This study shows there are more complications from surgery for thyroid cancer than expected. It suggests an opportunity to educate both patients and providers to decrease complications and improve outcomes," says senior study author Megan R. Haymart, M.D., assistant professor of metabolism, endocrinology and diabetes at Michigan Medicine.

The researchers identified three groups for which both general and thyroid surgery specific complications were more common:
  • Patients older than 65
  • Patients with more advanced thyroid cancer
  • Patients with other co-existing medical conditions

Older patients were about three times more likely to have complications than those younger than 65. Ten percent of older patients developed general post-operative complications and 19 percent had thyroid surgery-related complications. For patients younger than 65, 3 percent had general complications and 6 percent had thyroid surgery-related complications.

Advanced disease was associated with the highest number of complications: 23 percent of patients whose cancer had spread throughout the body had thyroid surgery specific complications, a number the researchers call "alarming."

"Thyroidectomy is considered a fairly safe operation in general, but some populations are more vulnerable and need extra attention in pre- and post-operative care," Papaleontiou says.

The researchers suggest better educating patients and providers so that those at risk of complications seek out high-volume surgeons that tend to have better outcomes. Other studies have shown that low-volume surgeons perform a disproportionate number of thyroid surgeries in the United States.

In addition, the researchers say it's crucial to educate endocrinologists - who typically treat hypoparathyroidism or hypocalcemia - on the likelihood of these risks on patients who have had thyroid cancer surgery.

In addition, Haymart says conversations about limiting surgery for those with low-risk disease may be appropriate.

"Even in low-risk patients, the risk of vocal cord paralysis is still 2 percent and the risk of hypoparathyroidism is 8 percent. This is higher than we'd like to see," Haymart says. "Are there options to do less extensive surgery for these patients? If the cancer control benefits are similar but the risks of long-term complications would be less, we need to provide patients with this option."
-end-
Papaleontiou and Haymart are both members of the University of Michigan Comprehensive Cancer Center and the Institute for Healthcare Policy and Innovation.

Additional authors: David T. Hughes, M.D.; Cui Guo, M.S.; Mousumi Banerjee, Ph.D.

Funding: National Institute on Aging grant K08 AG049684, National Cancer Institute grant R01 CA201198, Agency for Healthcare Research and Quality grant R01 HS024512

Disclosure: None

Reference: Journal of Clinical Endocrinology and Metabolism, doi.org/10.1210/jc.2017-00255, published online April 28, 2017

Resources:

University of Michigan Comprehensive Cancer Center, http://www.mcancer.org
Michigan Medicine Cancer AnswerLine, 800-865-1125
Michigan Health Lab, http://www.MichiganHealthLab.org

Michigan Medicine - University of Michigan

Related Cancer Articles:

Radiotherapy for invasive breast cancer increases the risk of second primary lung cancer
East Asian female breast cancer patients receiving radiotherapy have a higher risk of developing second primary lung cancer.
Cancer genomics continued: Triple negative breast cancer and cancer immunotherapy
Continuing PLOS Medicine's special issue on cancer genomics, Christos Hatzis of Yale University, New Haven, Conn., USA and colleagues describe a new subtype of triple negative breast cancer that may be more amenable to treatment than other cases of this difficult-to-treat disease.
Metabolite that promotes cancer cell transformation and colorectal cancer spread identified
Osaka University researchers revealed that the metabolite D-2-hydroxyglurate (D-2HG) promotes epithelial-mesenchymal transition of colorectal cancer cells, leading them to develop features of lower adherence to neighboring cells, increased invasiveness, and greater likelihood of metastatic spread.
UH Cancer Center researcher finds new driver of an aggressive form of brain cancer
University of Hawai'i Cancer Center researchers have identified an essential driver of tumor cell invasion in glioblastoma, the most aggressive form of brain cancer that can occur at any age.
UH Cancer Center researchers develop algorithm to find precise cancer treatments
University of Hawai'i Cancer Center researchers developed a computational algorithm to analyze 'Big Data' obtained from tumor samples to better understand and treat cancer.
New analytical technology to quantify anti-cancer drugs inside cancer cells
University of Oklahoma researchers will apply a new analytical technology that could ultimately provide a powerful tool for improved treatment of cancer patients in Oklahoma and beyond.
Radiotherapy for lung cancer patients is linked to increased risk of non-cancer deaths
Researchers have found that treating patients who have early stage non-small cell lung cancer with a type of radiotherapy called stereotactic body radiation therapy is associated with a small but increased risk of death from causes other than cancer.
Cancer expert says public health and prevention measures are key to defeating cancer
Is investment in research to develop new treatments the best approach to controlling cancer?
UI Cancer Center, Governors State to address cancer disparities in south suburbs
The University of Illinois Cancer Center and Governors State University have received a joint four-year, $1.5 million grant from the National Cancer Institute to help both institutions conduct community-based research to reduce cancer-related health disparities in Chicago's south suburbs.
Leading cancer research organizations to host international cancer immunotherapy conference
The Cancer Research Institute, the Association for Cancer Immunotherapy, the European Academy of Tumor Immunology, and the American Association for Cancer Research will join forces to sponsor the first International Cancer Immunotherapy Conference at the Sheraton New York Times Square Hotel in New York, Sept.

Related Cancer Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Climate Crisis
There's no greater threat to humanity than climate change. What can we do to stop the worst consequences? This hour, TED speakers explore how we can save our planet and whether we can do it in time. Guests include climate activist Greta Thunberg, chemical engineer Jennifer Wilcox, research scientist Sean Davis, food innovator Bruce Friedrich, and psychologist Per Espen Stoknes.
Now Playing: Science for the People

#527 Honey I CRISPR'd the Kids
This week we're coming to you from Awesome Con in Washington, D.C. There, host Bethany Brookshire led a panel of three amazing guests to talk about the promise and perils of CRISPR, and what happens now that CRISPR babies have (maybe?) been born. Featuring science writer Tina Saey, molecular biologist Anne Simon, and bioethicist Alan Regenberg. A Nobel Prize winner argues banning CRISPR babies won’t work Geneticists push for a 5-year global ban on gene-edited babies A CRISPR spin-off causes unintended typos in DNA News of the first gene-edited babies ignited a firestorm The researcher who created CRISPR twins defends...